
Dare Bioscience, Inc.
DARENasdaqCIK 1401914HealthcareFiscal year ends Dec 31
Reports and events: 320 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2025-02-1008:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005533 |
| 2025-01-1308:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-001871 |
| 2024-12-1608:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-050117 |
| 2024-11-1517:18 ET | S-1 | Registration statement | 0001493152-24-046346 |
| 2024-11-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-045860 |
| 2024-11-1416:01 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001401914-24-000041 |
| 2024-10-2508:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042455 |
| 2024-10-2312:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-042193 |
| 2024-10-2117:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-041796 |
| 2024-08-1216:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001401914-24-000038 |
| 2024-08-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-031252 |
| 2024-07-1908:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-028443 |
| 2024-06-2716:15 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-025435 |
| 2024-06-0716:05 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-023097 |
| 2024-05-1416:01 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001401914-24-000033 |
| 2024-05-1408:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019087 |
| 2024-04-3007:45 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-017147 |
| 2024-04-2616:15 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001401914-24-000027 |
| 2024-03-2816:01 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001401914-24-000016 |
| 2024-03-2808:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-011615 |
| 2024-01-2617:15 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-003984 |
| 2024-01-1916:30 ET | 8-K | 3.01 Delisting notice | 0001493152-24-003071 |
| 2024-01-0808:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-24-001663 |
| 2023-12-2608:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-046056 |
| 2023-12-2008:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-045515 |
| 2023-11-0917:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-23-040112 |
| 2023-11-0916:02 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001401914-23-000048 |
| 2023-11-0908:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-039997 |
| 2023-11-0108:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-038952 |
| 2023-10-1608:15 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-037290 |
| 2023-09-1108:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-23-032197 |
| 2023-08-3016:05 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-030659 |
| 2023-08-1016:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001401914-23-000045 |
| 2023-08-1008:05 ET | 8-K | 2.02 Results of operations; 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-23-027449 |
| 2023-07-2116:01 ET | 8-K | 3.01 Delisting notice | 0001401914-23-000042 |
| 2023-07-0508:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-023364 |
| 2023-06-2208:00 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-022075 |
| 2023-06-0508:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-020081 |
| 2023-05-1116:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001401914-23-000023 |
| 2023-05-1108:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-016287 |
| 2023-04-2716:01 ET | DEF 14A | Proxy statementPeriod 2023-06-21 | 0001401914-23-000015 |
| 2023-03-3116:22 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-23-010311 |
| 2023-03-3016:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001401914-23-000013 |
| 2023-03-3008:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-23-009600 |
| 2023-03-1308:20 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-007352 |
| 2023-02-0608:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-003634 |
| 2023-01-2717:15 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-23-002809 |
| 2023-01-2508:00 ET | 8-K | 8.01 Other events | 0001493152-23-002389 |
| 2023-01-0908:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-23-000904 |
| 2022-12-1617:10 ET | 8-K | 3.01 Delisting notice | 0001493152-22-035781 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:19 ET. Listed shows no prices and gives no investment advice.